The global brachytherapy market size reached US$ 856.4 Million in 2023. Looking forward, the market is projected to reach US$ 1.19 billion by 2032, exhibiting a growth rate (CAGR) of 3.78% during 2023-2032.
Brachytherapy, also known as internal radiation therapy, is a form of radiotherapy in which radiation is transported directly through a source implanted near or next to the cancerous tumor in the body. The source produces gamma rays that are focused on cancer cells and reduce the damage to surrounding healthy tissue. Brachytherapy is either administered in Low Dose Rate (LDR) or High Dose Rate (HDR) depending upon the severity of the disease and its damage. For LDR, small radioactive seeds are implanted permanently in or around the tumor, whereas, for HDR, radioactive sources are removed from the patient’s body at the termination of each session and is used in the cases of high-risk cancers.
The rising prevalence of different types of cancer is one of the key factors driving the global market. Brachytherapy has been proven to be an extremely effective treatment option for cervical, skin and breast cancers, which is contributing significantly to its market growth. Furthermore, the availability of high-quality brachytherapy equipment that provides accurate and extremely localized doses of radiation to small tumors has enhanced the acceptance of the therapy amongst patients and medical professionals alike.
Technological advancements in oncology treatments and extensive research and development (R&D), such as trials for treating neovascular age-related macular degeneration, have also provided a significant boost to the market growth. In addition to this, growing medical tourism across the globe, along with increasing awareness about the advantages of brachytherapy and its cost-effectiveness and increasing cure rate as compared to surgery or external beam therapy (EBT), is also significantly driving the market.
This report provides a deep insight into the global brachytherapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global brachytherapy market in any manner.
Breakup by Service Type:
2. What is the expected growth rate of the global brachytherapy market during 2024-2032?
3. What are the key factors driving the global brachytherapy market?
4. What has been the impact of COVID-19 on the global brachytherapy market?
5. What is the breakup of the global brachytherapy market based on the end user?
6. What are the key regions in the global brachytherapy market?
7. Who are the key players/companies in the global brachytherapy market?
Brachytherapy, also known as internal radiation therapy, is a form of radiotherapy in which radiation is transported directly through a source implanted near or next to the cancerous tumor in the body. The source produces gamma rays that are focused on cancer cells and reduce the damage to surrounding healthy tissue. Brachytherapy is either administered in Low Dose Rate (LDR) or High Dose Rate (HDR) depending upon the severity of the disease and its damage. For LDR, small radioactive seeds are implanted permanently in or around the tumor, whereas, for HDR, radioactive sources are removed from the patient’s body at the termination of each session and is used in the cases of high-risk cancers.
The rising prevalence of different types of cancer is one of the key factors driving the global market. Brachytherapy has been proven to be an extremely effective treatment option for cervical, skin and breast cancers, which is contributing significantly to its market growth. Furthermore, the availability of high-quality brachytherapy equipment that provides accurate and extremely localized doses of radiation to small tumors has enhanced the acceptance of the therapy amongst patients and medical professionals alike.
Technological advancements in oncology treatments and extensive research and development (R&D), such as trials for treating neovascular age-related macular degeneration, have also provided a significant boost to the market growth. In addition to this, growing medical tourism across the globe, along with increasing awareness about the advantages of brachytherapy and its cost-effectiveness and increasing cure rate as compared to surgery or external beam therapy (EBT), is also significantly driving the market.
This report provides a deep insight into the global brachytherapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global brachytherapy market in any manner.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global brachytherapy market report, along with forecasts at the global and regional level from 2024-2032. The report has categorized the market based on service type, technology, mode of procurement and end-user.Breakup by Service Type:
- History and Physical Report
- Discharge Summary
- Operative Note or Report
- Consultation Report
- Others (Pathology Report, Radiology Report, etc.)
Breakup by Technology:
- EMR/EHR
- PACS
- RIS
- SRT
- Others
Breakup by Mode of Procurement:
- Outsourcing
- Offshoring
- Both
- Hospitals
- Clinics
- Clinical Laboratories
- Academic Medical Centers
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape
The report has also analyzed the competitive landscape of the market with some of the key players being Acusis Software India Pvt Ltd., Transcend Services, Inc., Naunce Communications, Inc., MModal Global Services Pvt. Ltd., iMedX Information Services Pvt. Ltd., Global Medical Transcription LLC, nThrive Solutions LLC, MTBC (CareCloud, Inc.), Medi-Script Plus and Transtech Medical Solutions LLC.Key Questions Answered in This Report
1. What was the size of the global brachytherapy market in 2023?2. What is the expected growth rate of the global brachytherapy market during 2024-2032?
3. What are the key factors driving the global brachytherapy market?
4. What has been the impact of COVID-19 on the global brachytherapy market?
5. What is the breakup of the global brachytherapy market based on the end user?
6. What are the key regions in the global brachytherapy market?
7. Who are the key players/companies in the global brachytherapy market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Brachytherapy Market
6 Market Breakup by Service Type
7 Market Breakup by Technology
8 Market Breakup by Mode of Procurement
9 Market Breakup by End User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Acusis Software India Pvt Ltd.
- Transcend Services Inc.
- Naunce Communications Inc.
- MModal Global Services Pvt. Ltd.
- iMedX Information Services Pvt. Ltd.
- Global Medical Transcription LLC
- nThrive Solutions LLC
- MTBC (CareCloud Inc.)
- Medi-Script Plus
- Transtech Medical Solutions LLC
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 856.4 Billion |
| Forecasted Market Value ( USD | $ 1190 Billion |
| Compound Annual Growth Rate | 3.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
